462PA phase I open-label, non-randomized study of recombinant super-compound interferon (rSIFN-co) in patients with advanced solid tumours
Seet, A, Macapagal, M C F, Ahmad, A, Li, G, Goh, M L, Ng, M C H, Tan, T, Tan, D S W, Choo, S P, Lim, W T D, Tai, D W M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
145PClinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients
Kho, C Y X, Lim, D W-T, Tan, D S W, Tan, W L, Rajasekaran, T, Jain, A, Toh, C K, Ang, M-K, Tan, E H, Ng, Q S
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
25OUse of CTTA to predict treatment response in patients with EGFR T790M+ NSCLC treated with osimertinib
Tan, W L, Tran Nguyen, T A, Koh, T S, Priyanthi Hennedige, T, Yip, C S P, Tan, S H, Tan, D S W, Thng, C H, Lim, D W-T, Ng, Q S
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
523PReal world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore
Chua, B, Tan, E H, Lim, D W-T, Ang, M-K, Tan, D S W, Ng, Q-S, Kanesvaran, R, Jain, A, Tan, W-L, Toh, C K, Rajasekaran, T
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
1587TiP - CANOPY phase III program: Three studies evaluating canakinumab in patients with non-small cell lung cancer (NSCLC)
Paz-Ares, L., Garon, E.B., Ardizzoni, A., Barlesi, F., Cho, B.C., de Castro Junior, G., De Marchi, P., Felip, E., Goto, Y., Greystoke, A., Lu, S., Lim, D W-T, Papadimitrakopoulou, V.A., Reck, M., Solomon, B.J., Spigel, D., Tan, D.S.W., Thomas, M., Yang, J C-H, Johnson, B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1587TiPCANOPY phase III program: Three studies evaluating canakinumab in patients with non-small cell lung cancer (NSCLC)
Paz-Ares, L, Garon, E B, Ardizzoni, A, Barlesi, F, Cho, B C, de Castro Junior, G, De Marchi, P, Felip, E, Goto, Y, Greystoke, A, Lu, S, Lim, D W-T, Papadimitrakopoulou, V A, Reck, M, Solomon, B J, Spigel, D, Tan, D S W, Thomas, M, Yang, J C-H, Johnson, B
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
CANOPY phase III program: Three studies evaluating canakinumab in patients with non-small cell lung cancer (NSCLC)
Paz-Ares, L., Garon, E.B., Ardizzoni, A., Barlesi, F., Cho, B.C., de Castro Junior, G., De Marchi, P., Felip, E., Goto, Y., Greystoke, A., Lu, S., Lim, D W-T, Papadimitrakopoulou, V.A., Reck, M., Solomon, B.J., Spigel, D., Tan, D.S.W., Thomas, M., Yang, J C-H, Johnson, B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
104OIMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations
Reck, M, Jotte, R, Mok, T S K, Lim, D W-T, Cappuzzo, F, Orlandi, F, Stroyakovskiy, D, Nogami, N, Rodríguez-Abreu, D, Moro-Sibilot, D, Thomas, C A, Barlesi, F, Finley, G, Nishio, M, Lee, A, Shankar, G, Yu, W, Socinski, M A
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
LBA9IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations
Mok, T S K, Socinski, M A, Reck, M, Jotte, R M, Lim, D W-T, Cappuzzo, F, Orlandi, F J, Stroyakovskiy, D, Nogami, N, Rodríguez-Abreu, D, Moro-Siblot, D, Thomas, C A, Barlesi, F, Finley, G, Lee, A, Shankar, G, Yu, W, Kowanetz, M, Lin, W, Nishio, M
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
1921PSomatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma
Han, S, Yeong, J, Lim, C X, Ang, M-K, Lim, W T D, Toh, C K, Ng, Q S, Tan, D S, Lim, T K H, Loh, J H, Tanako, A, Kanesvaran, R, Tan, W L, Rajasekaran, T, Nei, W, Jain, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1452PCombination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation
Viteri, S, Chang, G-C, Chiari, R, Cho, B C, Ciardiello, F, Curigliano, G, Hida, T, Lee, D H, Lim, W T D, Lin, C-C, Martinez, A, Murakami, H, Natsume, I, Nishio, M, Paz-Ares, L, Soo, R A, Cattan, V, Gandossi, E, Heck, H, Park, K
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations
Reck, M., Jotte, R., Mok, T.S.K., Lim, D.W.-T., Cappuzzo, F., Orlandi, F., Stroyakovskiy, D., Nogami, N., Rodríguez-Abreu, D., Moro-Sibilot, D., Thomas, C.A., Barlesi, F., Finley, G., Nishio, M., Lee, A., Shankar, G., Yu, W., Socinski, M.A.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients
Kho, C.Y.X., Lim, D.W.-T., Tan, D.S.W., Tan, W.L., Rajasekaran, T., Jain, A., Toh, C.K., Ang, M.-K., Tan, E.H., Ng, Q.S.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations
Mok, T.S.K., Socinski, M.A., Reck, M., Jotte, R.M., Lim, D.W.-T., Cappuzzo, F., Orlandi, F.J., Stroyakovskiy, D., Nogami, N., Rodríguez-Abreu, D., Moro-Siblot, D., Thomas, C.A., Barlesi, F., Finley, G., Lee, A., Shankar, G., Yu, W., Kowanetz, M., Lin, W., Nishio, M.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore
Chua, B., Tan, E.H., Lim, D.W.-T., Ang, M.-K., Tan, D.S.W., Ng, Q.-S., Kanesvaran, R., Jain, A., Tan, W.-L., Toh, C.K., Rajasekaran, T.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Use of CTTA to predict treatment response in patients with EGFR T790M+ NSCLC treated with osimertinib
Tan, W L, Tran Nguyen, T A, Koh, T S, Priyanthi Hennedige, T, Yip, C S P, Tan, S H, Tan, D S W, Thng, C H, Lim, D W-T, Ng, Q S
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation
Viteri, S., Chang, G.-C., Chiari, R., Cho, B.C., Ciardiello, F., Curigliano, G., Hida, T., Lee, D.H., Lim, W.T.D., Lin, C.-C., Martinez, A., Murakami, H., Natsume, I., Nishio, M., Paz-Ares, L., Soo, R.A., Cattan, V., Gandossi, E., Heck, H., Park, K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma
Han, S., Yeong, J., Lim, C.X., Ang, M.-K., Lim, W.T.D., Toh, C.K., Ng, Q.S., Tan, D.S., Lim, T.K.H., Loh, J.H., Tanako, A., Kanesvaran, R., Tan, W.L., Rajasekaran, T., Nei, W., Jain, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article